ANTIHISTAMINE ORAL: The affected lot may contain concentrations of Ephedrine Hydrochloride and Pyrilamine Maleate that are outside the labeled concentration.

The affected lot may contain concentrations of Ephedrine Hydrochloride and Pyrilamine Maleate that are outside the labeled concentration.

Product safety

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.

ANTIHISTAMINE ORAL

RA-76709